biOasis Technologies Ord Shs BIOAF

EGF asset

[prophetoffactz]

BTI is tweeting its EGF asset. What could a deal be worth?

Phase II ready(full IND package).

Clinical experience already significantly addressing safety/tolerability risk leaving efficacy risk.

Unique mechanism of action addressing both inflammation and demyelination.

C$6 billion market(Guillain-Barre Syndrome, Chronic Inflammatory Degenerative Polyneuropathy and certain clinical manifestations related to onset and/or progression of multiple sclerosis including optic neuritis and relapses of the disease).

Validated by BTI's recent purchase and the Biodexa agreement which was further supported by Ladenberg Thalmann and Armistice Capital.

[zwerp2000]

zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz

[unclepieman]

Fake news

[fuzzyjr]

so what do you see as the best hope or move for Bti moving Prop?

[prophetoffactz]

Very tough time in the market. The S&P Biotech ETF is below where it was when the Midatech deal was announced. There has been a string of bank failures and there is concern the bank runs aren't over. An influencial JP Morgan analyst sees the growing risk of a Minsky Moment and total meltdown in the market. The market is more worried about the return of its money than speculation. And here

[fuzzyjr]

I believe they will get a deal/money but it's going to take something special to get this rolling again. glta